Combined Use of Magnetic Resonance Imaging and Biomarker Testing to Detect Clinically Significant Prostate Cancer. Review uri icon

Overview

abstract

  • We performed a narrative review of studies that produced clinically applicable data by examining the combined use of at least one biomarker test and multiparametric MRI to predict GG ≥2 prostate cancer on biopsy and by reporting the resultant clinical outcomes (i.e, the proportion of biopsies avoided and GG ≥2 cancers missed) following the application of various testing strategies incorporating these diagnostic tests.

publication date

  • February 1, 2023

Research

keywords

  • Multiparametric Magnetic Resonance Imaging
  • Prostatic Neoplasms

Identity

Scopus Document Identifier

  • 85142656203

Digital Object Identifier (DOI)

  • 10.1016/j.ucl.2022.09.008

PubMed ID

  • 36424086

Additional Document Info

volume

  • 50

issue

  • 1